MedPath

Effectiveness of CPP -ACP Chewing gums

Phase 4
Completed
Registration Number
CTRI/2018/03/012793
Lead Sponsor
Dr Vignesh D
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Undergraduate 1st and 2nd year dental students of the institution.

Study subjects who are willing to participate and give consent.

No report of use of antibiotics 3 months prior to the beginning of the study.

Absence of active dental caries and periodontitis.

Exclusion Criteria

Study subjects who were medically compromised or under any kind of

medications.

Study subjects undergoing orthodontic treatment.

Study subjects who are phenylketonurics.

Study subjects with a history of gastro intestinal problems.

Study subjects who are habitual chewing gum users.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The use of CPP - ACP chewing gums 2pellets/2 times/day leads to <br/ ><br>increased reductions in salivary levels of Streptococcus mutans even for short periods <br/ ><br>of 30 days and the effect was maintained even beyond interruption.Timepoint: The use of CPP - ACP chewing gums 2pellets/2 times/day leads to <br/ ><br>increased reductions in salivary levels of Streptococcus mutans even for short periods <br/ ><br>of 30 days and the effect was maintained even beyond interruption.
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath